Injective Logs $12.86 Billion in Onchain Trades in Its Fifth Year

Injective processed $12.86 billion in onchain trades during its fifth year of operation, according to figures released by the project, with perpetuals tied to real-world assets such as stocks and commodities accounting for $1.8 billion of that total. The measurement window ran from November 2025 to November 2026, a period in which the network also shipped three major technical upgrades. The numbers come from the protocol itself; no third-party audit accompanied the release.

The blockchain, which launched its mainnet on Nov. 8, 2021, supports markets for cryptocurrencies, tokenized stocks, foreign exchange and commodities, with settlement in USD Coin (USDC). Crypto perpetual contracts led activity across the year. Stock trading set monthly records from July through October, while spot volume rose 16-fold in September after governance voted to lower fees on flagship markets. In plain terms, the fee cut, not organic demand alone, coincided with the sharpest volume jump.

What did native EVM compatibility change?

Native Ethereum Virtual Machine compatibility went live on Nov. 11, 2025, allowing Ethereum developers to deploy applications on Injective using familiar tooling such as MetaMask and Hardhat. The design is notable for its plumbing: EVM applications share liquidity with applications built for WebAssembly (WASM), without bridges or wrapped tokens. Cross-chain bridges remain a recurring point of failure in the sector, so removing them from the architecture reduces one class of operational risk.

More than 30 applications and infrastructure providers joined on launch day, and transaction costs fell to fractions of a cent, according to the project. Whether those deployments translate into sustained usage was not addressed in the announcement.

How did oracle and issuance upgrades reshape costs?

Chainlink Data Streams delivered real-time prices for U.S. stocks and exchange-traded funds to the network in November 2025, a prerequisite for trading tokenized equities with credible price discovery. The June 2026 Vulcan upgrade then cut oracle update costs by 90% and added feeds for stocks and commodities — a reduction that matters because oracle costs are a direct constraint on how frequently onchain markets can refresh prices.

In September 2026, the Meridian upgrade enabled regulated token issuance and streamlined transactions for EVM applications. The claim of "regulated" issuance depends on jurisdictional specifics that the release did not enumerate, and readers should treat the term as a design goal rather than a verified legal status.

What comes next?

Injective published a white paper in October 2026 outlining a finance-focused blockchain strategy that includes real-world asset tokenization and institutional privacy. The document described CypherOS, an upcoming platform for privacy features. Institutional privacy on public infrastructure has drawn regulatory scrutiny elsewhere, and no launch date or technical specification accompanied the announcement.

The fifth-year figures position Injective as a credible venue for tokenized-asset trading, yet nearly all headline metrics originate from the protocol's own reporting. Independent verification of the $12.86 billion figure against onchain records would strengthen the case. The market should learn more as CypherOS moves from white paper to implementation.